首页 正文

Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy

{{output}}
Cancer immunotherapy has mostly relied on conventional T cells to achieve success in a limited set of tumor types. A promising avenue to expand the repertoire of cancers effectively treated through immune intervention is to mobilize other anti-tumor effectors,... ...